Global Transcranial Magnetic Stimulators (TMS) Market Growth 2025-2031

Global Transcranial Magnetic Stimulators (TMS) Market Growth 2025-2031

The global Transcranial Magnetic Stimulators (TMS) market size is predicted to grow from US$ 180 million in 2025 to US$ 452 million in 2031; it is expected to grow at a CAGR of 16.6% from 2025 to 2031.

Transcranial magnetic stimulator (TMS) is a medical device that uses magnetic fields to stimulate nerve cells in the brain. This non-invasive procedure involves placing a coil near the patient's scalp, generating magnetic pulses that influence neural activity. TMS is primarily used to treat neurological and psychiatric conditions such as depression, anxiety, and certain movement disorders. It is considered a safe and effective option for patients who do not respond well to conventional treatments like medication or psychotherapy.

A key driver of the transcranial magnetic stimulator (TMS) market is the rising prevalence of mental health disorders, particularly treatment-resistant depression and anxiety. As traditional therapies like medication and psychotherapy prove ineffective for some patients, there is increasing demand for alternative, non-invasive treatment options such as TMS. Additionally, growing awareness of TMS as a safe and effective intervention, coupled with technological advancements that improve its accessibility and precision, is driving market growth. A major challenge in the TMS market is the high cost of equipment and treatment sessions, which can limit accessibility for both healthcare providers and patients. TMS devices are expensive, and the treatments often require multiple sessions, making it a costly option for patients, particularly those without insurance coverage. Furthermore, limited awareness and availability of TMS in certain regions, as well as the need for trained professionals to administer the treatment, can create additional barriers to market expansion.

Global key players of transcranial magnetic stimulators (TMS) include Yiruide, Magstim, Neuronetics, etc. China is the largest producer of fNIRS brain imaging system, holds a share about 40%, followed by North America, and Europe. In terms of product, rTMS is the largest segment, with a share over 55%. And in terms of application, the largest segment is psychopharmacology, with a share over 45%.

LP Information, Inc. (LPI) ' newest research report, the “Transcranial Magnetic Stimulators (TMS) Industry Forecast” looks at past sales and reviews total world Transcranial Magnetic Stimulators (TMS) sales in 2024, providing a comprehensive analysis by region and market sector of projected Transcranial Magnetic Stimulators (TMS) sales for 2025 through 2031. With Transcranial Magnetic Stimulators (TMS) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transcranial Magnetic Stimulators (TMS) industry.

This Insight Report provides a comprehensive analysis of the global Transcranial Magnetic Stimulators (TMS) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Transcranial Magnetic Stimulators (TMS) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Transcranial Magnetic Stimulators (TMS) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transcranial Magnetic Stimulators (TMS) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transcranial Magnetic Stimulators (TMS).

This report presents a comprehensive overview, market shares, and growth opportunities of Transcranial Magnetic Stimulators (TMS) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
rTMS
sTMS
pTMS
Others

Segmentation by Application:
Psychopharmacology
Neurology
Rehabilitation Department
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Yiruide
Neuronetics
Magstim
MagVenture
Neurosoft
Brainsway
eNeura
Remed
Nexstim
MAG & More
Jiangxi Brain Modulate
VISHEE
YINGCHI
Junjian Wanfeng

Key Questions Addressed in this Report

What is the 10-year outlook for the global Transcranial Magnetic Stimulators (TMS) market?

What factors are driving Transcranial Magnetic Stimulators (TMS) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Transcranial Magnetic Stimulators (TMS) market opportunities vary by end market size?

How does Transcranial Magnetic Stimulators (TMS) break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.